Literature DB >> 27247628

Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction.

Yana Barbalat1, Marissa C Velez1, Christopher I Sayegh1, Doreen E Chung2.   

Abstract

In 2005, the high power thulium laser was introduced for the surgical treatment of benign prostatic obstruction. It has several properties that confer theoretical advantages over other lasers used for the same indication, such as technical versatility and a relatively small zone of thermal damage. Studies using the 70-150 W thulium laser systems demonstrate good efficacy of these procedures with low morbidity and few complications even in higher risk patients. Different techniques have been employed to treat the prostate with this technology, including enucleation, vapoenucleation, vaporization and resection. Comparative studies have been published comparing thulium laser prostatectomy to monopolar transurethral resection of prostate (TURP), bipolar TURP and holmium laser enucleation of prostate (HoLEP). In this review we discuss the current literature on the safety and efficacy of various thulium techniques for the treatment of benign prostatic hyperplasia and examine comparative studies.

Entities:  

Keywords:  laser therapy; prostatic hyperplasia; thulium

Year:  2016        PMID: 27247628      PMCID: PMC4872189          DOI: 10.1177/1756287216632429

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  37 in total

1.  Evaluation of the Learning Curve for Holmium Laser Enucleation of the Prostate Using Multiple Outcome Measures.

Authors:  Oliver Brunckhorst; Kamran Ahmed; Osayuki Nehikhare; Giancarlo Marra; Ben Challacombe; Richard Popert
Journal:  Urology       Date:  2015-08-04       Impact factor: 2.649

2.  Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment.

Authors:  Shu-Jie Xia
Journal:  Asian J Androl       Date:  2009-04-27       Impact factor: 3.285

3.  Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.

Authors:  Steffen Rausch; Thomas Heider; Jens Bedke; Stephan Kruck; Christian Schwentner; Karsten Fischer; Arnulf Stenzl; Tilman Kälble
Journal:  Urology       Date:  2015-01       Impact factor: 2.649

4.  Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers.

Authors:  Feng Sun; Bangmin Han; Di Cui; Fujun Zhao; Xiaowen Sun; Jian Zhuo; Yifeng Jing; Haitao Liu; Shujie Xia; Yong Yang; Guangheng Luo; Fengfu Guo
Journal:  World J Urol       Date:  2014-12-09       Impact factor: 4.226

5.  Urologic diseases in America project: benign prostatic hyperplasia.

Authors:  John T Wei; Elizabeth Calhoun; Steven J Jacobsen
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

6.  Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.

Authors:  Xinhua Yu; Sean P Elliott; Timothy J Wilt; A Marshall McBean
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

7.  A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results.

Authors:  Di Cui; Feng Sun; Jian Zhuo; Xiaowen Sun; Bangmin Han; Fujun Zhao; Yifeng Jing; Jun Lu; Shujie Xia
Journal:  World J Urol       Date:  2013-08-03       Impact factor: 4.226

8.  Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.

Authors:  Roman Szlauer; Robert Götschl; Aria Razmaria; Ljiljana Paras; Nikolaus T Schmeller
Journal:  Eur Urol       Date:  2008-11-12       Impact factor: 20.096

9.  Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study.

Authors:  Ching-Hsin Chang; Tzu-Ping Lin; Yen-Hwa Chang; William J S Huang; Alex T L Lin; Kuang-Kuo Chen
Journal:  BMC Urol       Date:  2015-05-09       Impact factor: 2.264

10.  Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients.

Authors:  Fabrizio Iacono; Domenico Prezioso; Giovanni Di Lauro; Giuseppe Romeo; Antonio Ruffo; Ester Illiano; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more
  5 in total

1.  Transurethral vaporesection of prostate: diode laser or thulium laser?

Authors:  Xinji Tan; Xiaobo Zhang; Dongjie Li; Xiong Chen; Yuanqing Dai; Jie Gu; Mingquan Chen; Sheng Hu; Yao Bai; Yu Ning
Journal:  Lasers Med Sci       Date:  2018-04-10       Impact factor: 3.161

Review 2.  Bladder Neck Contracture After Endoscopic Surgery for Benign Prostatic Obstruction: Incidence, Treatment, and Outcomes.

Authors:  Giulia Primiceri; Pietro Castellan; Michele Marchioni; Luigi Schips; Luca Cindolo
Journal:  Curr Urol Rep       Date:  2017-08-09       Impact factor: 3.092

3.  Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction.

Authors:  Fu-Shun Hsu; Chen-Wei Chou; Hong-Chiang Chang; Yuan-Po Tu; Shing-Jia Sha; Huang-Hsin Chung; Kuo-How Huang
Journal:  Sci Rep       Date:  2019-04-23       Impact factor: 4.379

4.  Holmium laser versus thulium laser enucleation of the prostate: a matched-pair analysis from two centers.

Authors:  Giacomo Maria Pirola; Giovanni Saredi; Ricardo Codas Duarte; Lorraine Bernard; Andrea Pacchetti; Lorenzo Berti; Eugenio Martorana; Giulio Carcano; Lionel Badet; Hakim Fassi-Fehri
Journal:  Ther Adv Urol       Date:  2018-06-07

Review 5.  Assessment of Sexual Outcomes in Patients Undergoing Thulium Laser Prostate Surgery for Management of Benign Prostate Hyperplasia: A Systematic Review and Meta-analysis.

Authors:  Bibo Li; Lin Hao; Kun Pang; Guanghui Zang; Jian Wang; Chendi Yang; Jianjun Zhang; Longjun Cai; Xitao Wang; Conghui Han
Journal:  Sex Med       Date:  2022-01-16       Impact factor: 2.523

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.